🇺🇸 MRK — Merck & Co., Inc.

Healthcare Compra
← Volver

Precio actual

150,33 USD

Máx. histórico

156,92

10 días

Caída desde máximo

-4,20%

Rango 52 semanas

77,58 – 156,92

Variación hoy

-1,32%

Cierre anterior

152,34

Rango de hoy

150,09 – 152,22

Volumen hoy

4.298.143

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
122,22 (puede no estar actualizado)
Dividend yield
2,23% (puede no estar actualizado)
Precio objetivo analistas
148,73 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 2 días
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,3600 USD · Yield: 2,24%
Fecha de pago Importe por participación
02/12/1992 0,1193 USD
31/08/1992 0,1193 USD
02/06/1992 0,1097 USD
02/03/1992 0,1097 USD
02/12/1991 0,1002 USD
30/08/1991 0,1002 USD
03/06/1991 0,0891 USD
04/03/1991 0,0891 USD
03/12/1990 0,0891 USD
28/08/1990 0,0891 USD
29/05/1990 0,0716 USD
05/03/1990 0,0716 USD
04/12/1989 0,0716 USD
29/08/1989 0,0716 USD
30/05/1989 0,0652 USD
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
15/03/2018 52,43 53,18 52,38 52,72 +0,82% 1,53% 10.560.277
14/03/2018 52,74 52,89 51,82 52,29 -1,03% 2,03% 11.692.222
13/03/2018 53,19 53,20 52,48 52,83 +0,02% 1,35% 12.272.080
12/03/2018 53,18 53,56 52,71 52,82 +0,40% 1,60% 11.269.039
09/03/2018 52,51 52,66 52,19 52,61 +0,69% 0,89% 9.240.006
08/03/2018 52,02 52,31 51,87 52,25 +0,53% 0,84% 7.705.001
07/03/2018 51,37 52,08 51,29 51,98 +0,31% 1,54% 12.817.564
06/03/2018 51,99 52,20 51,36 51,81 -0,18% 1,63% 9.716.951
05/03/2018 51,76 52,20 51,60 51,91 +0,07% 1,16% 13.743.577
02/03/2018 51,03 51,94 50,69 51,87 +1,23% 2,45% 9.355.706
01/03/2018 51,77 52,30 50,97 51,24 -0,96% 2,56% 13.648.523
28/02/2018 52,54 52,64 51,73 51,74 -0,91% 1,74% 11.807.606
27/02/2018 53,35 53,40 52,19 52,21 -2,39% 2,25% 9.734.453
26/02/2018 52,48 53,62 52,48 53,49 +2,17% 2,16% 12.725.026
23/02/2018 52,31 52,48 52,07 52,36 +0,55% 0,78% 9.499.177
22/02/2018 52,10 52,55 51,93 52,07 +0,04% 1,19% 11.334.958
21/02/2018 52,51 52,90 52,05 52,05 -0,78% 1,62% 11.244.935
20/02/2018 53,55 53,57 52,43 52,46 -2,33% 2,12% 14.113.416
16/02/2018 53,41 54,38 53,36 53,71 +0,54% 1,91% 12.294.402
15/02/2018 52,89 53,43 52,32 53,43 +1,99% 2,09% 10.584.695
14/02/2018 51,82 52,58 51,74 52,39 +0,00% 1,62% 11.996.142
13/02/2018 52,70 52,83 52,26 52,39 -0,96% 1,09% 17.857.291
12/02/2018 52,81 53,33 52,44 52,89 +1,02% 1,68% 13.259.506
09/02/2018 52,62 52,87 50,92 52,36 +0,26% 3,72% 19.472.364
08/02/2018 53,47 53,87 52,20 52,22 -2,06% 3,12% 21.871.760
07/02/2018 52,64 54,11 52,57 53,32 +0,76% 2,94% 14.349.740
06/02/2018 52,61 54,17 51,84 52,92 -1,67% 4,43% 32.494.498
05/02/2018 55,60 56,25 53,26 53,82 -3,69% 5,37% 20.546.774
02/02/2018 56,69 57,22 55,61 55,88 -2,17% 2,84% 12.852.777
01/02/2018 56,46 57,58 56,36 57,12 +1,03% 2,15% 14.009.664